Prescription drug · ANDA
Rivastigmine NDC 70771-1950
Rivastigmine 9.5 mg/24h · Patch, Extended release · Transdermal · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1950-7 | 70771195007 | 30 POUCH in 1 CARTON (70771-1950-7) / 24 h in 1 POUCH (70771-1950-1)Marketed from Mar 6, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rivastigmine
- Generic name (nonproprietary)
- rivastigmine
- Active ingredients
- Rivastigmine — 9.5 mg/24h
- Dosage form
- Patch, Extended release
- Route
- Transdermal
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206318
- Marketing start
- Listing expires
- Other FDA classes
- Cholinesterase Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1950_eb52b342-1672-42e7-bb4c-9c8f1bce7fc3SPL ID eb52b342-1672-42e7-bb4c-9c8f1bce7fc3SPL set ID 966d59ea-5cea-4fef-8b96-e0efe885caf4RxCUI 725021, 725023, 1308569UNII PKI06M3IW0
- Pharmacologic class
- Cholinesterase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771195007followed by a unit qualifier and the quantityPackage 70771-1950-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 206318
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Northstar Rx LLC. | 16714-116 |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Zydus Lifesciences Limited | 70771-1951 |
| Rivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Zydus Lifesciences Limited | 70771-1949 |
| Rivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Zydus Pharmaceuticals USA Inc. | 70710-1196 |
| Rivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Zydus Pharmaceuticals USA Inc. | 70710-1197 |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Zydus Pharmaceuticals USA Inc. | 70710-1198 |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Northstar Rx LLC. | 16714-117 |